CTIS & Europe

EU clinical-trial submissions through CTIS.

CTIS is the single entry point for medicinal-product clinical-trial applications under the EU Clinical Trials Regulation.

One submission system. National assessment roles.

CTIS supports interactions between sponsors and regulatory authorities across EU Member States and EEA countries. National competent authorities and ethics committees participate in assessment. The UK and Switzerland follow separate national routes.

EU/EEA national competent-authority terminology

Terminology index only. Check current national requirements before every submission.

Central & Western Europe

Austria — BASG
Belgium — FAMHP / FAGG
France — ANSM
Germany — BfArM and PEI
Ireland — HPRA
Luxembourg — Ministry of Health
Netherlands — CBG-MEB

Northern Europe

Denmark — DKMA
Estonia — State Agency of Medicines
Finland — Fimea
Iceland — Icelandic Medicines Agency
Latvia — State Agency of Medicines
Lithuania — SMCA
Norway — Norwegian Medical Products Agency
Sweden — MPA

Southern & Eastern Europe

Bulgaria — BDA
Croatia — HALMED
Czechia — SÚKL
Greece — EOF
Hungary — NNGYK
Italy — AIFA
Malta — Medicines Authority
Poland — URPL
Portugal — INFARMED
Romania — ANMDMR
Slovakia — ŠÚKL
Slovenia — JAZMP
Spain — AEMPS

Official resources